RGEN Share Price

Open 32.01 Change Price %
High 32.32 1 Day -0.27 -0.83
Low 31.41 1 Week 1.11 3.58
Close 32.13 1 Month 3.31 11.49
Volume 132259 1 Year 6.35 24.63
52 Week High 34.06
52 Week Low 21.11
RGEN Important Levels
Resistance 2 32.97
Resistance 1 32.63
Pivot 31.95
Support 1 31.63
Support 2 31.29
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Repligen Corporation (NASDAQ: RGEN)

RGEN Technical Analysis 4
As on 24th Feb 2017 RGEN Share Price closed @ 32.13 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 29.09 & Buy for SHORT-TERM with Stoploss of 31.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
RGEN Target for February
1st Target up-side 32.89
2nd Target up-side 34.89
3rd Target up-side 36.89
1st Target down-side 27.19
2nd Target down-side 25.19
3rd Target down-side 23.19
RGEN Other Details
Segment EQ
Market Capital 156846352.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.repligen.com
RGEN Address
RGEN
Building 1
Suite 100
Waltham, MA 02453
United States
Phone: 781-250-0111
Fax: 781-250-0115
RGEN Latest News
Interactive Technical Analysis Chart Repligen Corporation ( RGEN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Repligen Corporation
RGEN Business Profile
Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies several growth factor products used to increase cell culture productivity in biomanufacturing. The Company develops and markets a series of OPUS (Open Platform User Specified) single-use chromatography columns used in the biologics purification process.